IONIX PHARMACEUTICALS
Ionix Pharmaceuticals, based in Cambridge UK, is a leader in the discovery and development of new analgesic medicines for the treatment of acute and chronic pain. Using proprietary drug targets and state-of-the-art chemistry, the company is developing medicines that are designed to alleviate pain associated with trauma, operative procedures, and debilitating diseases such as arthritis, diabetes and multiple sclerosis. Ionix Pharmaceuticals is a privately held company and was founded in 2001.
IONIX PHARMACEUTICALS
Industry:
Health Care Medical Pharmaceutical
Founded:
2001-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Total Employee:
101+
Status:
Active
Total Funding:
27.2 M USD
Similar Organizations
Aprea
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Aptarion biotech
Aptarion biotech is a developer Biostable L-Aptamers for the treatment Of Life-Threatening diseases And for Biosensors.
Curadis GmbH
Curadis GmbH provides researches and develops steroidal medicines for breast cancer and benign enlargement.
Ennar Pharma
Development of medicines for the treatment of psoriasis.
Pharmion
Pharmion engages in the acquisition, development, and commercialization of products for the treatment of hematology and oncology patients.
Investors List
Wellcome Trust
Wellcome Trust investment in Series B - Ionix Pharmaceuticals
Apax Partners
Apax Partners investment in Series B - Ionix Pharmaceuticals